FBXL16 Promotes Endometrial Progesterone Resistance via PP2AB55α/Cyclin D1 Axis in Ishikawa
Background. F-box proteins are essential components of the E3 ubiquitin ligases which are involved in the regulation of almost all life activities such as cell cycle, proliferation, and apoptosis, which have become an important research and drug target. However, there are few studies on F-box and le...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2022/7372202 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832562279022854144 |
|---|---|
| author | Haoen Liu Li Han Liyan Zhong Xiaodan Zhuang Yan Peng |
| author_facet | Haoen Liu Li Han Liyan Zhong Xiaodan Zhuang Yan Peng |
| author_sort | Haoen Liu |
| collection | DOAJ |
| description | Background. F-box proteins are essential components of the E3 ubiquitin ligases which are involved in the regulation of almost all life activities such as cell cycle, proliferation, and apoptosis, which have become an important research and drug target. However, there are few studies on F-box and leucine-rich repeat protein 16 (FBXL16) in endometrial carcinoma. Methods. Clinical samples were collected for determining the correlation between FBXL16 and endometrial carcinoma. Cells were screened and established with Ishikawa cells which proved the fundamental role of FBXL16 in regulating cell proliferation and cell cycle. The MPA-resistant endometrial carcinoma cell line Ishikawa/MPA was established. FBXL16, PP2AB55α, and cyclin D1 were analyzed separately in MPA sensitive and resistant Ishikawa cells in vitro and in vivo. Results. The high expression of FBXL16 was positively correlated with MPA resistance and poor prognosis of endometrial cancer. MPA tolerance of endometrial cancer cells was inhibited by knockdown of FBXL16 in DNA content assessment, CCK-8, and colony formation. It was confirmed that FBXL16 inhibited the activity of substrate PP2AB55α by binding to PP2A, reduced the phosphorylation level at Thr308 site of AKT1, inhibited the expression of GSK-3β, and thus led to a significant decrease in the phosphorylation level of cyclin D1, which prevented the ubiquitination recognition and degradation of cyclin D1. Conclusion. In our experiments, FBXL16 binds PP2A to promote the dephosphorylation of Thr286 site of cyclin D1 via AKT1/GSK3β/cyclin D1 pathway, which is required for resisting the ubiquitination degradation and enhances the MPA resistance of Ishikawa. |
| format | Article |
| id | doaj-art-9e9ac944d9a343129748bf5111b0f590 |
| institution | Kabale University |
| issn | 2314-7156 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-9e9ac944d9a343129748bf5111b0f5902025-02-03T01:22:59ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/7372202FBXL16 Promotes Endometrial Progesterone Resistance via PP2AB55α/Cyclin D1 Axis in IshikawaHaoen Liu0Li Han1Liyan Zhong2Xiaodan Zhuang3Yan Peng4Wujin Hospital Affiliated with Jiangsu UniversityNilek County People’s HospitalWujin Hospital Affiliated with Jiangsu UniversityWujin Hospital Affiliated with Jiangsu UniversityWujin Hospital Affiliated with Jiangsu UniversityBackground. F-box proteins are essential components of the E3 ubiquitin ligases which are involved in the regulation of almost all life activities such as cell cycle, proliferation, and apoptosis, which have become an important research and drug target. However, there are few studies on F-box and leucine-rich repeat protein 16 (FBXL16) in endometrial carcinoma. Methods. Clinical samples were collected for determining the correlation between FBXL16 and endometrial carcinoma. Cells were screened and established with Ishikawa cells which proved the fundamental role of FBXL16 in regulating cell proliferation and cell cycle. The MPA-resistant endometrial carcinoma cell line Ishikawa/MPA was established. FBXL16, PP2AB55α, and cyclin D1 were analyzed separately in MPA sensitive and resistant Ishikawa cells in vitro and in vivo. Results. The high expression of FBXL16 was positively correlated with MPA resistance and poor prognosis of endometrial cancer. MPA tolerance of endometrial cancer cells was inhibited by knockdown of FBXL16 in DNA content assessment, CCK-8, and colony formation. It was confirmed that FBXL16 inhibited the activity of substrate PP2AB55α by binding to PP2A, reduced the phosphorylation level at Thr308 site of AKT1, inhibited the expression of GSK-3β, and thus led to a significant decrease in the phosphorylation level of cyclin D1, which prevented the ubiquitination recognition and degradation of cyclin D1. Conclusion. In our experiments, FBXL16 binds PP2A to promote the dephosphorylation of Thr286 site of cyclin D1 via AKT1/GSK3β/cyclin D1 pathway, which is required for resisting the ubiquitination degradation and enhances the MPA resistance of Ishikawa.http://dx.doi.org/10.1155/2022/7372202 |
| spellingShingle | Haoen Liu Li Han Liyan Zhong Xiaodan Zhuang Yan Peng FBXL16 Promotes Endometrial Progesterone Resistance via PP2AB55α/Cyclin D1 Axis in Ishikawa Journal of Immunology Research |
| title | FBXL16 Promotes Endometrial Progesterone Resistance via PP2AB55α/Cyclin D1 Axis in Ishikawa |
| title_full | FBXL16 Promotes Endometrial Progesterone Resistance via PP2AB55α/Cyclin D1 Axis in Ishikawa |
| title_fullStr | FBXL16 Promotes Endometrial Progesterone Resistance via PP2AB55α/Cyclin D1 Axis in Ishikawa |
| title_full_unstemmed | FBXL16 Promotes Endometrial Progesterone Resistance via PP2AB55α/Cyclin D1 Axis in Ishikawa |
| title_short | FBXL16 Promotes Endometrial Progesterone Resistance via PP2AB55α/Cyclin D1 Axis in Ishikawa |
| title_sort | fbxl16 promotes endometrial progesterone resistance via pp2ab55α cyclin d1 axis in ishikawa |
| url | http://dx.doi.org/10.1155/2022/7372202 |
| work_keys_str_mv | AT haoenliu fbxl16promotesendometrialprogesteroneresistanceviapp2ab55acyclind1axisinishikawa AT lihan fbxl16promotesendometrialprogesteroneresistanceviapp2ab55acyclind1axisinishikawa AT liyanzhong fbxl16promotesendometrialprogesteroneresistanceviapp2ab55acyclind1axisinishikawa AT xiaodanzhuang fbxl16promotesendometrialprogesteroneresistanceviapp2ab55acyclind1axisinishikawa AT yanpeng fbxl16promotesendometrialprogesteroneresistanceviapp2ab55acyclind1axisinishikawa |